CellCept transplant drug effectively treats aHUS in…
CellCept (mycophenolate mofetil), an oral immunosuppressant used to prevent organ rejection, has been shown to be effective in treating a 10-year-old girl with severe atypical hemolytic uremic syndrome (aHUS). The researchers emphasized the importance of early diagnosis and careful monitoring in the recovery of patients. The study, “Atypical haemolytic uremic syndrome (aHUS) sensitive to mycophenolate …
CellCept transplant drug effectively treats aHUS in… Read More »
